SLC34A1 and nonpapillary renal cell carcinoma: Our results revealed that the expression of SLC34A1 phosphoprotein at the T623S625, S625, and S34 phosphorylation sites was significantly lower in primary ccRCC tumors than in normal renal tissues (P < 0.001) (Fig. 10C–E).